CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX)

CUSIP: 14888U101

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / Common Stock
Shares outstanding
123,180,519
Total 13F shares
67,671,701
Share change
+1,114,702
Total reported value
$311,885,548
Put/Call ratio
48%
Price per share
$4.61
Number of holders
130
Value change
+$10,809,324
Number of buys
64
Number of sells
60

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 14888U101?
CUSIP 14888U101 identifies CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) as of Q1 2021

As of 31 Mar 2021, CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) was held by 130 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 67,671,701 shares. The largest 10 holders included ARMISTICE CAPITAL, LLC, STATE STREET CORP, BlackRock Inc., VANGUARD GROUP INC, ROYCE & ASSOCIATES LP, PRUDENTIAL FINANCIAL INC, GEODE CAPITAL MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, LSV ASSET MANAGEMENT, and ACADIAN ASSET MANAGEMENT LLC. This page lists 130 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders
131
Q1 2021 holders
130
Holder diff
-1
Investor Q4 2020 Shares Q1 2021 Shares Share Diff Share Chg % Q4 2020 Value $ Q1 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.